Geron Corporation

149 Commonwealth Drive, Menlo Park, CA 94025

Public
Healthcare & Pharmaceuticals - Pharmaceuticals
around $10 - 20M
around 100 - 250
(650) 473-7700
(302) 636-5454


Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Imetelstat exhibits relatively preferential inhibition of the clonal proliferation of malignant progenitor cells in nonclinical studies. Janssen is engaged in the development of Imetelstat with over two clinical trials, such as a Phase I... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Geron Corporation?


28 Contacts at this company
Julia Mensing
Executive Assistant
Bart Burington
Vice President, Biometrics
Cheryl Northern
Administrative Assistant
Igal Geron
Sr. Manager People Analytics
Geron Farro
Senior Mechanical Engineer
Thibaut Géron
Associate Structured Acquisition Finance ...
Tony Geron
Accounts Manager
Dana Geron
Tel Aviv University
M. Geron Gadd
Legal Director

No company news available.
Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.